News

PCI may add Pharm D as a qualification for appointment of Registrar of State Pharmacy Councils: Gireesh Babu, New Delhi ...
SEC recommends to upgrade Corbevax from restricted use in emergency situation to new drug: Gireesh Babu, New Delhi Monday, ...
Neutron Therapeutics & Helsinki University Hospital treat first head and neck cancer patients using accelerator-based boron neutron capture therapy: Helsinki, Finland Monday, May ...
Acadia Pharma gets favourable ruling from Delaware District Court in Nuplazid formulation patent litigation: San Diego Monday, May 19, 2025, 17:00 Hrs [IST] Acadia Pharmaceuticals ...
Cytecare highlights at vital role of Oncoanesthesia CANCON 2025: Our Bureau, Bengaluru Monday, May 19, 2025, 17:15 Hrs [IST] CANCON 2025, the event hosted at Cytecare Hospitals, t ...
Venus Remedies joins United Nations Global Compact, reinforcing commitment to sustainable global healthcare: Our Bureau, Bengaluru Monday, May 19, 2025, 16:45 Hrs [IST] Venus Reme ...
China NMPA grants marketing approval to CANbridge’s velaglucerase-beta for injection to trat Type I and III Gaucher disease: Suzhou, China Monday, May 19, 2025, 14:00 Hrs [IST] ...
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved guselkumab (Tremfya) to treat Crohn’s disease and ulcerative colitis (UC). The approval was granted on 16th May, 2025 to ...
EMA’s ETF recommends updating Covid-19 vaccines to target new LP.8.1 variant: Amsterdam, The Netherlands Monday, May 19, 2025, 10:00 Hrs [IST] European Medicines Agency’s (EMA ...
Oracle, Cleveland Clinic & G42 enter strategic partnership to launch AI-based global healthcare delivery platform: Abu Dhabi, UAE Monday, May 19, 2025, 14:30 Hrs [IST] Oracle Heal ...
BioMarin Pharmaceutical Inc. and Inozyme Pharma, Inc. announced that BioMarin has entered into a definitive agreement to acquire Inozyme for $4.00 per share in an all-cash transaction for a total ...